Home / Recalls / Precision Dose Inc. / D-0741-2026

D-0741-2026 Class II Ongoing

Recalled by Precision Dose Inc. — South Beloit, IL

FDA drug recall D-0741-2026 was initiated by Precision Dose Inc. on Jul 14, 2026 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications The recall status is ongoing.

Recall Details

Product Type: Drugs
Report Date: Jul 29, 2026
Initiation Date: Jul 14, 2026
Voluntary/Mandated: Voluntary: Firm initiated

Product Description

Glycopyrrolate Oral Solution, 1 mg/5 mL, delivers 5 mL, Rx only, Pkg: Precision Dose, Inc, S. Beloil, IL 61080, unit-dose oral syringes, NDCs 68094-073-01 (oral syringe) and 68094-073-58 (case).

Reason for Recall

Failed Impurities/Degradation Specifications

Distribution Pattern

US Nationwide.

Code Information

Lot # 506033, Exp Date: 11/30/2026.

Source

Dataset: openFDA drug recall enforcement reports
FDA record: This recall in openFDA (JSON)
Enforcement Report: Search FDA's Enforcement Report for D-0741-2026
openFDA file date: Nov 3, 2026
Loaded by RegDataLab: Nov 4, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Other recalls by Precision Dose Inc.

D-0094-2022 Class II — Acetaminophen Oral Suspension, 160 mg/5 mL, packaged in 5 mL per cup (NDC… (Nov 1, 2021)
D-0095-2022 Class II — Acetaminophen Oral Suspension, 325 mg/10.15 mL, packaged in 10.15 mL per cup… (Nov 1, 2021)
D-0228-2021 Class II — Chlorhexidine Gluconate Oral Rinse USP 0.12%, packaged in a) 15 mL x 30 Unit… (Jan 1, 2021)
D-1004-2020 Class II — Ranitidine Oral Solution, USP, 150 mg/10 mL, [10 mL x 30 Unit Dose Cups per… (Nov 13, 2019)
D-0057-2018 Class III — Carbamazepine Oral Suspension USP, 100 mg/5 mL, 5 mL Unit Dose Cups (NDC… (Sep 25, 2017)
D-1037-2017 Class II — Carbamazepine Oral Suspension, USP. 100 mg/5 mL, 5 mL Unit Dose Cups, Rx Only… (Jul 5, 2017)
D-250-2013 Class II — Children's Acetaminophen Oral Suspension, 650 mg/20.3 mL unit dose cup (NDC… (Mar 21, 2013)